Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
Neurology and Therapy
|
August 5, 2023
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
Andrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, et al.
Drug Safety
|
May 19, 2019
Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study
Paul K Winner, Andrew M Blumenfeld, Eric J Eross, et al.
Nucleic Acids Research
|
November 25, 1993
Oligonucleotide circularization by template-directed chemical ligation
N G Dolinnaya, M Blumenfeld, I N Merenkova, et al.
Neurology
|
November 17, 2022
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial
Richard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.
Headache
|
April 5, 2021
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction study
Abhijeet Jakate, Andrew M Blumenfeld, Ramesh Boinpally, et al.
Pain and Therapy
|
February 12, 2026
Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Chronic Migraine and Concomitant Therapeutic Indications
Andrew M Blumenfeld, Christopher Rhyne, Kenneth Martinez, et al.
Headache
|
February 3, 2016
Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey
Andrew Messali, Joanna C Sanderson, Andrew M Blumenfeld, et al.
Cephalalgia : an International Journal of Headache
|
September 4, 2010
Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)
A M Blumenfeld, S F Varon, T K Wilcox, et al.
Journal of Chromatography
|
August 3, 1984
Preparation of histone variants and high-mobility group proteins by reversed-phase high-performance liquid chromatography
L R Gurley, J A D'Anna, M Blumenfeld, et al.
Headache
|
January 18, 2023
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial
Messoud Ashina, Stewart J Tepper, Uwe Reuter, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
Neurology and Therapy
|
August 5, 2023
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
Andrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, et al.
Drug Safety
|
May 19, 2019
Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study
Paul K Winner, Andrew M Blumenfeld, Eric J Eross, et al.
Nucleic Acids Research
|
November 25, 1993
Oligonucleotide circularization by template-directed chemical ligation
N G Dolinnaya, M Blumenfeld, I N Merenkova, et al.
Neurology
|
November 17, 2022
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial
Richard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.
Headache
|
April 5, 2021
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction study
Abhijeet Jakate, Andrew M Blumenfeld, Ramesh Boinpally, et al.
Pain and Therapy
|
February 12, 2026
Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Chronic Migraine and Concomitant Therapeutic Indications
Andrew M Blumenfeld, Christopher Rhyne, Kenneth Martinez, et al.
Headache
|
February 3, 2016
Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey
Andrew Messali, Joanna C Sanderson, Andrew M Blumenfeld, et al.
Cephalalgia : an International Journal of Headache
|
September 4, 2010
Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)
A M Blumenfeld, S F Varon, T K Wilcox, et al.
Journal of Chromatography
|
August 3, 1984
Preparation of histone variants and high-mobility group proteins by reversed-phase high-performance liquid chromatography
L R Gurley, J A D'Anna, M Blumenfeld, et al.
Headache
|
January 18, 2023
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial
Messoud Ashina, Stewart J Tepper, Uwe Reuter, et al.
Page
of 12